Plectonic Biotech
Pre-clinicalPlectonic Biotech pioneers the next era of targeted therapeutics through its proprietary Logibody technology. With a foundation in DNA nanotechnology, our mission is to develop highly specific and effective molecular therapies that redefine precision medicine.
Founded
2018
Focus
Drug DeliverySynthetic Biology
About
Plectonic Biotech pioneers the next era of targeted therapeutics through its proprietary Logibody technology. With a foundation in DNA nanotechnology, our mission is to develop highly specific and effective molecular therapies that redefine precision medicine.
Funding History
1Total raised: $2.5M
Seed$2.5MHigh-Tech GründerfondsJun 15, 2022
Company Info
TypePrivate
Founded2018
LocationMunich, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile